Record NNP B-NP O
date NN I-NP O
: : O O
2084-12-12 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
030 CD B-NP B-STREET
Nashua NNP I-NP I-STREET
Mall NNP I-NP I-STREET
Street NNP I-NP I-STREET
FAIR NNP I-NP I-PATIENT
, , O I-PATIENT
BILL NNP B-NP I-PATIENT
Plymouth NNP B-NP B-CITY
, , O O
IN IN B-PP B-STATE
46368 CD B-NP B-ZIP
22041864 CD I-NP B-MEDICALRECORD
----------- DT B-NP O
12/12/8 CD I-NP I-DATE
4 CD O I-DATE
ATTENDING VBG B-NP O
PHYSICIAN NNP I-NP O
: : O O
Elizabeth NNP B-NP B-DOCTOR
Keys NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
CHIEF JJ B-NP O
COMPLAINT NNP I-NP O
: : O O
diabetes NN B-NP O
management NN I-NP O
. . O O
HISTORY NN B-NP O
OF IN B-PP O
PRESENT JJ B-NP O
ILLNESS NNS I-NP O
: : O O
Mr. NNP B-NP O
Fair NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
61 CD I-NP B-AGE
-year-old JJ I-NP O
patient NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
diabetes NN B-NP O
diagnosed VBD B-VP O
more JJR B-NP O
than IN I-NP O
20 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O
He PRP B-NP O
has VBZ B-VP O
known VBN I-VP O
complication NN B-NP O
of IN B-PP O
retinopathy NN B-NP O
and CC O O
is VBZ B-VP O
status NN B-NP O
post NN I-NP O
bilateral JJ I-NP O
laser NN I-NP O
surgery NN I-NP O
about IN B-PP O
one CD B-NP O
year NN I-NP O
ago RB B-ADVP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
known VBN I-NP O
neuropathy NN I-NP O
or CC I-NP O
nephropathy NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
known JJ I-NP O
history NN I-NP O
of IN B-PP O
CAD NN B-NP O
, , O O
CVA NNP B-NP O
or CC O O
PVD. NNP B-NP O
He PRP B-NP O
had VBD B-VP O
previously RB I-VP O
been VBN I-VP O
followed VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Elizabeth NNP I-NP B-DOCTOR
Keys NNP I-NP I-DOCTOR
at IN B-PP O
Pioneer NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
at IN B-PP O
Findlay NNP B-NP B-CITY
until IN B-PP O
June NNP B-NP B-DATE
of IN B-PP O
this DT B-NP O
year NN I-NP O
which WDT B-NP O
time NN B-VP O
he PRP B-NP O
switched VBD B-VP O
to TO B-PP O
a DT B-NP O
new JJ I-NP O
primary JJ I-NP O
care NN I-NP O
doctor NN I-NP O
. . O O
At IN B-PP O
that DT B-NP O
time NN I-NP O
, , O O
he PRP B-NP O
had VBD B-VP O
been VBN I-VP O
on IN B-PP O
glyburide NN B-NP O
, , I-NP O
metformin NN I-NP O
and CC I-NP O
Avandia NNP I-NP O
, , O O
his PRP$ B-NP O
new JJ I-NP O
PCP NNP I-NP O
increased VBD B-VP O
his PRP$ B-NP O
glyburide NN I-NP O
and CC O O
his PRP$ B-NP O
Avandia NNP I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
stopped VBD B-VP O
his PRP$ B-NP O
hydrochlorothiazide NN I-NP O
out IN B-PP O
of IN B-PP O
concern NN B-NP O
that IN B-SBAR O
this DT B-NP O
is VBZ B-VP O
not RB O O
an DT B-NP O
ideal JJ I-NP O
agent NN I-NP O
for IN B-PP O
a DT B-NP O
diabetic JJ I-NP O
patient NN I-NP O
. . O O
Over IN B-PP O
the DT B-NP O
next JJ I-NP O
weeks NNS I-NP O
to TO B-PP O
months NNS B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
progressive JJ B-NP O
peripheral JJ I-NP O
edema NN I-NP O
, , O O
fluid NN B-NP O
weight NN I-NP O
gain NN I-NP O
and CC O O
ultimately RB B-ADVP O
development NN B-NP O
of IN B-PP O
dyspnea NN B-NP O
on IN B-PP O
exertion NN B-NP O
, , I-NP O
orthopnea NN I-NP O
and CC I-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
. . O O
He PRP B-NP O
returned VBD B-VP O
for IN B-PP O
care NN B-NP O
and CC O O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
furosemide NN B-NP O
and CC O O
has VBZ B-VP O
been VBN I-VP O
recently RB I-VP O
titrated VBN I-VP O
up RP B-PRT O
to TO B-PP O
a DT B-NP O
dose NN I-NP O
of IN B-PP O
60 CD B-NP O
mg NN I-NP O
orally RB B-ADVP O
on IN B-PP O
this DT B-NP O
. . O O
He PRP B-NP O
self NN B-VP O
adjusted VBN I-VP O
his PRP$ B-NP O
Avandia NNP I-NP O
dose NN I-NP O
from IN B-PP O
4 CD B-NP O
mg NN I-NP O
twice RB B-ADVP O
daily RB I-ADVP O
to TO B-PP O
2 CD B-NP O
mg CD I-NP O
daily RB B-ADVP O
. . B-VP O
His PRP$ B-NP O
prebreakfast NN I-NP O
blood NN I-NP O
glucose NN I-NP O
has VBZ B-VP O
been VBN I-VP O
elevated VBN I-VP O
ranging VBG I-VP O
from IN B-PP O
160-200 CD B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
some DT B-NP O
resolution NN I-NP O
of IN B-PP O
his PRP$ B-NP O
fluid NN I-NP O
overload RB B-ADVP O
with IN B-PP O
the DT B-NP O
Lasix NNP I-NP O
and CC O O
lower JJR B-NP O
dose NN I-NP O
Avandia NNS I-NP O
. . O O
He PRP B-NP O
says VBZ B-VP O
he PRP B-NP O
has VBZ B-VP O
persistent JJ B-NP O
feeling NN I-NP O
of IN B-PP O
swelling VBG B-NP O
and CC I-NP O
tightness VBG I-NP O
in IN B-PP O
his PRP$ B-NP O
fingers NNS I-NP O
and CC I-NP O
toes NNS I-NP O
with IN B-PP O
episodic JJ B-NP O
ankle NN I-NP O
swelling VBG B-VP O
as RB B-ADVP O
well RB I-ADVP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
claudication NN B-NP O
polyuria NN I-NP O
, , O O
polydipsia NN B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
losing VBG I-VP O
weight NN B-NP O
since IN B-PP O
starting VBG B-NP O
Lasix NNP I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
never RB I-VP O
had VBD I-VP O
hypoglycemia NN B-NP O
. . O O
DIABETES NNS B-NP O
SURVELLIANCE NNP I-NP O
AND CC I-NP O
MANAGEMENT NNP I-NP O
: : O O
Hemoglobin NNP B-NP O
A1c NNP I-NP O
11.4 CD I-NP O
% NN I-NP O
( -LRB- O O
10/01/8 CD B-NP I-DATE
4 CD I-NP I-DATE
) -RRB- I-NP O
. . O O
Cholesterol NNP B-NP O
190 CD I-NP O
, , O O
LDL NNP B-NP O
cholesterol NN I-NP O
190 CD B-NP O
, , O O
HDL NNP B-NP O
49 CD I-NP O
( -LRB- I-NP O
10/01/8 CD I-NP I-DATE
4 CD I-NP I-DATE
) -RRB- I-NP O
and CC O O
LDL NNP B-NP O
118 CD I-NP O
( -LRB- I-NP O
07/02/8 CD I-NP I-DATE
4 CD I-NP I-DATE
) -RRB- I-NP O
. . O O
Microalbumin NNP B-NP O
to TO B-VP O
creatinine VB I-VP O
19 CD B-NP O
( -LRB- I-NP O
07/02/8 CD I-NP I-DATE
4 CD I-NP I-DATE
) -RRB- I-NP O
. . O O
Creatinine NNP B-NP O
0.9 CD I-NP O
( -LRB- I-NP O
07/02/8 CD I-NP I-DATE
4 CD I-NP I-DATE
) -RRB- I-NP O
. . O O
Last JJ B-NP O
eye NN I-NP O
exam NN I-NP O
09/8 IN B-PP I-DATE
3 CD B-NP I-DATE
. . O O
Pneumovax NNP B-NP O
never RB B-ADVP O
. . O O
Influenza NNP B-NP O
vaccine NN I-NP O
never RB B-ADVP O
. . O O
Aspirin NNP B-NP O
325 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
. . O O
ACE NNP B-NP O
inhibitor NN I-NP O
yes RB B-ADVP O
( -LRB- B-VP O
lisinopril NN B-NP O
10 CD B-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
) -RRB- I-NP O
. . O O
Statin NNP B-NP O
yes RB I-NP O
( -LRB- O O
Lipitor NNP B-NP O
40 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
) -RRB- I-NP O
. . O O
PAST NN B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Diabetes NNP B-NP O
as IN I-NP O
above RB B-ADVP O
. . O O
Diabetic JJ B-NP O
retinopathy NN I-NP O
. . O O
Hypertension NNP B-NP O
. . O O
Osteoarthritis NNP B-NP O
of IN B-PP O
the DT B-NP O
knees NNS I-NP O
. . O O
Status NNP B-NP O
post NN I-NP O
hammertoe NN I-NP O
repair NN I-NP O
. . O O
Pilonidal NNP B-NP O
cyst NN I-NP O
status NN I-NP O
post NN I-NP O
I&D. . O O
Severed JJ B-NP O
Achilles NNP I-NP O
tendon CD I-NP O
status NN I-NP O
post NN I-NP O
repair NN I-NP O
. . O O
Right RB B-ADVP O
meniscus JJ B-NP O
removal NN I-NP O
. . O O
MEDICATIONS NNS B-NP O
: : O O
Glyburide NNP B-NP O
10 CD B-NP O
mg NN I-NP O
twice RB B-ADVP O
daily RB I-ADVP O
, , O O
metformin NN B-NP O
1000 CD I-NP O
mg NN I-NP O
twice RB B-ADVP O
daily RB I-ADVP O
and CC O O
the DT B-NP O
Avandia NNP I-NP O
2 CD I-NP O
mg , O O
daily RB B-ADVP O
, , O O
Lipitor NNP B-NP O
40 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
lisinopril JJ I-NP O
10 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
. . I-NP O
furosemide JJ I-NP O
60 CD I-NP O
mg NN I-NP O
daily RB B-ADVP O
, , O O
multivitamin NN B-NP O
one CD I-NP O
tablet NN I-NP O
daily JJ I-NP O
and CC I-NP O
Viagra NNP I-NP O
as IN B-PP O
needed VBN B-NP O
. . O O
ALLERGIES NNS B-NP O
: : O O
Amoxicillin NNP B-NP O
gives VBZ B-VP O
him PRP B-NP O
a DT B-NP O
rash NN I-NP O
. . O O
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Noncontributory NN B-NP O
. . O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
: : O O
He PRP B-NP O
works VBZ B-VP O
as IN B-SBAR O
a DT B-NP O
manager NN I-NP B-PROFESSION
in IN B-PP I-PROFESSION
a DT B-NP I-PROFESSION
convenience NN I-NP I-PROFESSION
store NN I-NP I-PROFESSION
, , O O
he PRP B-NP O
lives VBZ B-VP O
with IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
kids NNS I-NP O
. . O O
He PRP B-NP O
does VBZ B-VP O
not RB I-VP O
exercise VB I-VP O
secondary JJ B-ADJP O
to TO B-PP O
joint JJ B-NP O
pain NN I-NP O
. . O O
He PRP B-NP O
tends VBZ B-VP O
to TO I-VP O
eat VB I-VP O
a DT B-NP O
lot NN I-NP O
of IN B-PP O
carbohydrates NNS B-NP O
and CC I-NP O
meats NNS I-NP O
although IN B-SBAR O
he PRP B-NP O
does VBZ B-VP O
not RB I-VP O
have VB I-VP O
a DT B-NP O
sweet JJ I-NP O
tooth NN I-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
tobacco NN B-NP O
, , I-NP O
alcohol NN I-NP O
or CC I-NP O
recreational JJ I-NP O
drug NN I-NP O
use NN I-NP O
. . O O
REVIEW NN B-NP O
OF IN B-PP O
SYSTEMS NNP B-NP O
: : O O
As IN B-PP O
per IN B-PP O
HPI NNP B-NP O
, , O O
otherwise RB B-ADVP O
, , O O
negative JJ B-ADJP O
. . O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
: : O O
His PRP$ B-NP O
weight NN I-NP O
is VBZ B-VP O
270 CD B-NP O
pounds NNS I-NP O
, , O O
his PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
is VBZ B-VP O
150/92 CD B-NP O
and CC O O
then RB B-NP O
155/92 CD I-NP O
to TO B-PP O
my PRP$ B-NP O
a DT I-NP O
repeat NN I-NP O
exam NN I-NP O
, , O O
pulse NN B-NP O
is VBZ B-VP O
70 CD B-NP O
and CC I-NP O
regular JJ I-NP O
. . O O
In IN B-PP O
general JJ B-ADJP O
, , O O
he PRP B-NP O
is VBZ B-VP O
a DT B-NP O
well-appearing JJ I-NP O
gentleman NN I-NP O
in IN B-PP O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
. . O O
His PRP$ B-NP O
skin NN I-NP O
is VBZ B-VP O
warm JJ B-ADJP O
and CC I-ADJP O
dry JJ I-ADJP O
. . O O
Extraocular JJ B-NP O
movements NNS I-NP O
are VBP B-VP O
intact JJ B-ADJP O
. . O O
Oropharynx NNP B-NP O
is VBZ B-VP O
clear JJ B-ADJP O
. . O O
Mucous JJ B-NP O
membranes NNS I-NP O
are VBP B-VP O
moist JJ B-ADJP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
. . O O
His PRP$ B-NP O
thyroid NN I-NP O
is VBZ B-VP O
normal JJ B-ADJP O
in IN B-PP O
size NN B-NP O
and CC I-NP O
contour NN I-NP O
. . O O
Lung NNP B-NP O
exam NN I-NP O
reveals VBZ B-VP O
crackles NNS B-NP O
at IN B-PP O
the DT B-NP O
bases NNS I-NP O
. . O O
His PRP$ B-NP O
heart NN I-NP O
is VBZ B-VP O
regular JJ B-ADJP O
in IN B-PP O
rate NN B-NP O
and CC I-NP O
rhythm NN I-NP O
with IN B-PP O
an DT B-NP O
S1 NNP I-NP O
, , I-NP O
S2 NNP I-NP O
, , I-NP O
without IN B-PP O
S3 NNP B-NP O
or CC I-NP O
S4 NNP I-NP O
. . I-NP O
Abdomen NNP I-NP O
is VBZ B-VP O
obese JJ B-ADJP O
, , O O
soft JJ B-ADJP O
and CC I-ADJP O
nontender JJ I-ADJP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP O
. . O O
His PRP$ B-NP O
extremities NNS I-NP O
are VBP B-VP O
without IN B-PP O
clubbing VBG B-NP O
or CC I-NP O
cyanosis NN I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
2+ JJ B-NP O
pitting NN I-NP O
edema NN I-NP O
to TO B-PP O
the DT B-NP O
ankles NNS I-NP O
. . O O
His PRP$ B-NP O
foot NN I-NP O
exam NN I-NP O
reveals VBZ B-VP O
that IN B-PP O
his PRP$ B-NP O
distal JJ I-NP O
pulses NNS I-NP O
are VBP B-VP O
okay JJ B-ADJP O
. . O O
Sensation NNP B-NP O
is VBZ B-VP O
intact JJ B-ADJP O
to TO B-VP O
monofilament VB I-VP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
skin NN I-NP O
breakdown NN I-NP O
or CC I-NP O
ulcerations NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
an DT B-NP O
extensive JJ I-NP O
onychomycosis NN I-NP O
of IN B-PP O
the DT B-NP O
nails NNS I-NP O
bilaterally RB B-ADVP O
. . O O
Glucose NNP B-NP O
132 CD I-NP O
. . O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
61 CD I-NP B-AGE
-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-PP O
type NN B-NP O
II NNP I-NP O
diabetes NN I-NP O
complicated VBN B-VP O
by IN B-PP O
retinopathy JJ B-NP O
and CC I-NP O
erectile JJ I-NP O
dysfunction NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
inadequate JJ B-NP O
glycemic JJ I-NP O
control NN I-NP O
on IN B-PP O
oral JJ B-NP O
agents NNS I-NP O
which WDT B-NP O
are VBP B-VP O
currently RB B-ADVP O
at IN B-PP O
their PRP$ B-NP O
maximal JJ I-NP O
doses NNS I-NP O
given VBN B-VP O
the DT B-NP O
intolerable JJ I-NP O
side NN I-NP O
effects NNS I-NP O
of IN B-PP O
Avandia NNP B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
plans NNS B-NP O
for IN B-PP O
elective JJ B-NP O
knee NN I-NP O
replacement NN I-NP O
during IN B-PP O
the DT B-NP O
spring NN I-NP B-DATE
and CC O O
we PRP B-NP O
have VBP B-VP O
advised VBN I-VP O
him PRP B-NP O
that IN B-PP O
before IN B-SBAR O
he PRP B-NP O
consider VBP B-VP O
that IN B-SBAR O
he PRP B-NP O
should MD B-VP O
get VB I-VP O
his PRP$ B-NP O
diabetes NNS I-NP O
under IN B-PP O
better JJR B-NP O
control NN I-NP O
, , O O
should MD B-VP O
make VB I-VP O
sure JJ B-ADJP O
his PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
is VBZ B-VP O
controlled VBN I-VP O
and CC O O
should MD B-VP O
seek VB I-VP O
cardiac JJ B-NP O
evaluation NN I-NP O
, , O O
especially RB B-VP O
given VBN I-VP O
his PRP$ B-NP O
history NN I-NP O
of IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
symptoms NNS I-NP O
on IN B-PP O
Avandia NNP B-NP O
. . O O
1 CD B-NP O
. . O O
We PRP B-NP O
will MD B-VP O
start VB I-VP O
insulin NN B-NP O
today NN I-NP O
initially RB B-ADVP O
NPH RB B-NP O
25 CD I-NP O
units NNS I-NP O
at IN B-PP O
bedtime NN B-NP O
to TO B-VP O
replace VB I-VP O
his PRP$ B-NP O
evening NN I-NP O
dose NN I-NP O
of IN B-PP O
glyburide NN B-NP O
. . O O
We PRP B-NP O
have VBP B-VP O
instructed VBN I-VP O
him PRP B-NP O
on IN B-PP O
use NN B-NP O
of IN B-PP O
the DT B-NP O
Inolet NNP I-NP O
for IN B-PP O
insulin NN B-NP O
administration NN I-NP O
. . O O
He PRP B-NP O
will MD B-VP O
continue VB I-VP O
his PRP$ B-NP O
glyburide NN I-NP O
10 CD I-NP O
mg NN I-NP O
each DT B-NP O
morning NN I-NP O
, , O O
continue VBP B-VP O
metformin NN B-NP O
1000 CD I-NP O
mg NN I-NP O
twice RB B-ADVP O
daily RB I-ADVP O
and CC O O
Avandia NNP B-NP O
2 CD I-NP O
mg NN I-NP O
each DT B-NP O
morning NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
check VB I-VP O
hemoglobin NN B-NP O
A1c JJ I-NP O
today NN I-NP O
as IN B-PP O
a DT B-NP O
baseline NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
follow VB I-VP O
up RP B-PRT O
to TO B-VP O
determine VB I-VP O
appropriate JJ B-NP O
titration NN I-NP O
of IN B-PP O
his PRP$ B-NP O
insulin NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
addition NN B-NP O
of IN B-PP O
other JJ B-NP O
doses NNS I-NP O
during IN B-PP O
the DT B-NP O
day NN I-NP O
. . O O
2. VBG B-VP O
His PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
is VBZ B-VP O
not RB I-VP O
optimally RB I-VP O
controlled VBN I-VP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
increase VB I-VP O
his PRP$ B-NP O
lisinopril NN I-NP O
to TO B-PP O
40 CD B-NP O
mg CD I-NP O
daily JJ B-ADJP O
. . O O
He PRP B-NP O
will MD B-VP O
continue VB I-VP O
his PRP$ B-NP O
furosemide NN I-NP O
60 CD B-NP O
mg NN I-NP O
daily RB B-ADVP O
and CC O O
he PRP B-NP O
will MD B-VP O
continue VB I-VP O
to TO I-VP O
titrate VB I-VP O
his PRP$ B-NP O
Lasix NNP I-NP O
dosing NN I-NP O
at IN B-PP O
the DT B-NP O
guidance NN I-NP O
of IN B-PP O
his PRP$ B-NP O
primary JJ I-NP O
care NN I-NP O
doctor NN I-NP O
. . O O
3. DT B-NP O
His PRP$ I-NP O
last JJ I-NP O
microalbumin NN I-NP O
to TO B-VP O
creatinine VB I-VP O
ratio NN B-NP O
and CC O O
creatinine CD B-NP O
were VBD B-VP O
normal JJ B-ADJP O
. . O O
Testing NNP B-NP O
is VBZ B-VP O
up-to-date JJ B-ADJP O
. . O O
4 LS O O
. . O O
The DT B-NP O
patient NN I-NP O
has VBZ B-VP O
an DT B-NP O
LDL NNP I-NP O
that WDT B-NP O
was VBD B-VP O
above IN B-PP O
target NN B-NP O
this DT B-NP O
summer NN I-NP B-DATE
and CC O O
Lipitor NNP B-NP O
was VBD B-VP O
initiated VBN I-VP O
; : O O
however RB B-ADVP O
, , O O
he PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
on IN B-PP O
this DT B-NP O
long JJ I-NP O
enough JJ B-ADJP O
to TO B-VP O
see VB I-VP O
an DT B-NP O
effect NN I-NP O
. . O O
At IN B-ADVP O
his PRP$ B-NP O
next JJ I-NP O
visit NN I-NP O
, , O O
we PRP B-NP O
will MD B-VP O
reevaluate VB I-VP O
his PRP$ B-NP O
lipids NNS I-NP O
to TO B-VP O
determine VB I-VP O
if IN B-PP O
his PRP$ B-NP O
Lipitor NNP I-NP O
needs NNS I-NP O
titration NN I-NP O
. . O O
5 CD B-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
overdue JJ B-ADJP O
for IN B-PP O
an DT B-NP O
eye NN I-NP O
exam NN I-NP O
and CC O O
will MD B-VP O
contact VB I-VP O
Dr. NNP B-NP O
Xuereb NNP I-NP B-DOCTOR
at IN B-PP O
Findlay NNP B-NP B-CITY
him PRP B-NP O
to TO B-VP O
have VB I-VP O
this DT B-NP O
done VBN I-NP O
. . O O
6 CD B-NP O
. . O O
We PRP B-NP O
have VBP B-VP O
made VBN I-VP O
a DT B-NP O
referral NN I-NP O
to TO B-PP O
Dr. NNP B-NP O
Liam NNP I-NP B-DOCTOR
Mcmahon NNP I-NP I-DOCTOR
for IN B-PP O
cardiology NN B-NP O
evaluation NN I-NP O
. . O O
We PRP B-NP O
have VBP B-VP O
ordered VBN I-VP O
an DT B-NP O
echocardiogram NN I-NP O
to TO B-VP O
be VB I-VP O
performed VBN I-VP O
prior RB B-ADVP O
to TO B-PP O
this DT B-NP O
visit NN I-NP O
. . O O
We PRP B-NP O
have VBP B-VP O
also RB I-VP O
referred VBN I-VP O
the DT B-NP O
patient NN I-NP O
to TO B-PP O
a DT B-NP O
number NN I-NP O
of IN B-PP O
possible JJ B-NP O
PCPs NNS I-NP O
in IN B-PP O
the DT B-NP O
OMC NNP I-NP B-HOSPITAL
/ NNP I-NP O
CBC NNP I-NP B-HOSPITAL
system NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
advised VBN I-VP O
to TO I-VP O
return VB I-VP O
to TO B-PP O
the DT B-NP O
office NN I-NP O
in IN B-PP O
two CD B-NP O
months NNS I-NP O
for IN B-PP O
follow VBP B-VP O
up RP B-PRT O
. . O O
Florence NNP B-NP B-DOCTOR
Mildred NNP I-NP I-DOCTOR
Yuan NNP I-NP I-DOCTOR
, , O O
MD . O O
Dictated NNP B-NP O
By IN I-NP O
: : O O
Florence NNP B-NP B-DOCTOR
Mildred NNP I-NP I-DOCTOR
Yuan NNP I-NP I-DOCTOR
eScription NN B-NP O
document NN I-NP O
: : O O
2-8940866 CD B-NP B-IDNUM
EMSSten NNP I-NP O
Tel NNP I-NP O
DD NNP B-NP O
: : O O
12/16/8 CD B-NP I-DATE
4 CD I-NP I-DATE
DT NNP B-NP O
: : O O
12/16/8 CD B-NP I-DATE
4 CD I-NP I-DATE
DV NNP B-NP O
: : O O
12/12/8 CD B-NP I-DATE
4 CD I-NP I-DATE
